Resveratrol

insulin ; Homo sapiens







112 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 29018489 Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis. 2017 2
52 26968895 Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. 2016 Jun 2
53 27035655 CLOCK and BMAL1 Regulate Muscle Insulin Sensitivity via SIRT1 in Male Mice. 2016 Jun 1
54 27133915 The combination of 1α,25dihydroxyvitaminD3 with resveratrol improves neuronal degeneration by regulating endoplasmic reticulum stress, insulin signaling and inhibiting tau hyperphosphorylation in SH-SY5Y cells. 2016 Jul 2
55 27456934 The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials. 2016 Dec 1
56 27520400 Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. 2016 Sep 1
57 27754722 Effects of Resveratrol on Polycystic Ovary Syndrome: A Double-blind, Randomized, Placebo-controlled Trial. 2016 Nov 2
58 27852684 Resveratrol as Add-on Therapy in Subjects With Well-Controlled Type 2 Diabetes: A Randomized Controlled Trial. 2016 Dec 2
59 25138371 Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus--systematic review and meta-analysis. 2015 Jan 2
60 25139462 Novel strategies for preventing diabetes and obesity complications with natural polyphenols. 2015 2
61 25445538 Resveratrol and diabetes: from animal to human studies. 2015 Jun 1
62 25451966 Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. 2015 Jun 1
63 25534140 Thoughts on the progression of type 2 diabetes drug discovery. 2015 Feb 1
64 25562512 Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells. 2015 Mar 4
65 25577300 Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. 2015 Mar 2
66 25606815 Dietary Antioxidants as Modifiers of Physiologic Adaptations to Exercise. 2015 Sep 1
67 25612477 Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance. 2015 2
68 25647160 Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. 2015 1
69 25897359 Tyrosine isomers and hormonal signaling: A possible role for the hydroxyl free radical in insulin resistance. 2015 Apr 15 2
70 25941821 Application of resveratrol in diabetes: rationale, strategies and challenges. 2015 1
71 26305052 Proposed trial: safety and efficacy of resveratrol for the treatment of non-alcoholic fatty liver disease (NAFLD) and associated insulin resistance in adolescents who are overweight or obese adolescents - rationale and protocol. 2015 Oct 2
72 26364558 Authors' reply to the comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. 2015 Dec 1
73 26382727 Comment on "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial" by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226-32]. 2015 Dec 1
74 24582567 Resveratrol does not benefit patients with nonalcoholic fatty liver disease. 2014 Dec 1
75 24606795 Mitochondrial biogenesis: pharmacological approaches. 2014 1
76 24695890 Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. 2014 Jun 5
77 25137036 Effect of resveratrol administration on metabolic syndrome, insulin sensitivity, and insulin secretion. 2014 Dec 3
78 25245999 Resveratrol, inositol, vitamin D and K in the prevention of cardiovascular and osteoporotic risk: a novel approach in peri- and postmenopause. 2014 Oct 1
79 29872461 Resveratrol for the Management of Diabetes and its Downstream Pathologies. 2014 Feb 1
80 23315205 Resveratrol directly affects in vitro lipolysis and glucose transport in human fat cells. 2013 Sep 1
81 23436883 Diabetic complications in pregnancy: is resveratrol a solution? 2013 May 1
82 23624181 Resveratrol vs. calorie restriction: data from rodents to humans. 2013 Oct 1
83 23884882 Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. 2013 Oct 1
84 24073011 Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. 2013 2
85 24199159 SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. 2013 Oct 1
86 26064836 High-dose Resveratrol Inhibits Insulin Signaling Pathway in 3T3-L1 Adipocytes. 2013 Mar 3
87 22219517 Pilot study of resveratrol in older adults with impaired glucose tolerance. 2012 Dec 2
88 22437738 Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies. 2012 Apr 3
89 22564731 SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. 2012 Jun 1 1
90 22898769 Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells. 2012 Nov 3
91 22917016 Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells. 2012 Sep 12 3
92 21163946 Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. 2011 Feb 25 3
93 21241768 Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. 2011 Mar 30 6
94 21261639 Anti-diabetic effects of resveratrol. 2011 Jan 4
95 21367579 Polyphenols: planting the seeds of treatment for the metabolic syndrome. 2011 Jun 1
96 21385509 Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. 2011 Aug 8
97 21483037 Resveratrol-activated SIRT1 in liver and pancreatic β-cells: a Janus head looking to the same direction of metabolic homeostasis. 2011 Apr 1
98 21689891 Resveratrol may be beneficial in treatment of diabetic foot syndrome. 2011 Sep 1
99 20463039 Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. 2010 Jul 1
100 20823772 Resveratrol: a relevant pharmacological approach for the treatment of metabolic syndrome? 2010 Nov 1